arrow
J

Jens Kühle

University Hospital and University Basel
H指数:90
被引数:3.4万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Macro- and microstructural changes in the upper cervical spinal cord and their clinical correlates in multiple sclerosis

多发性硬化症中上颈椎脊髓的宏观和微观结构变化及其临床相关性

2026-10-090
PRE
Retinal vessel diameters in multiple sclerosis: associations with disability, cardiovascular risk factors and retinal atrophy

多发性硬化患者的视网膜血管直径:与残疾、心血管危险因素和视网膜萎缩的关联

2026-09-280
PRE
A community-validated tool for clinical outcome calculation in multiple sclerosis: Consensus development and scenario-specific recommendations

一种用于多发性硬化症临床结局计算的社区验证工具:共识制定和特定场景建议

2026-08-220
PRE
Evaluation of Dried Plasma Spot-Based Quantification of Glial Fibrillary Acidic Protein as a Disease-Associated Biomarker in Neuromyelitis Optica Spectrum Disorder

基于干血斑的胶质纤维酸性蛋白定量评估作为视神经脊髓炎谱系障碍的疾病相关生物标志物

2026-08-200
OAAI
Retinal layers prognosticate cognitive progression independent of relapse activity in multiple sclerosis

视网膜层预测多发性硬化认知进展,独立于复发活动

2026-08-060
OA
Treatment escalation after clinically silent MRI lesions in relapsing-remitting multiple sclerosis

在复发缓解型多发性硬化中,针对临床静息期MRI病灶的治疗升级

Brain
IF11.7
2026-07-240
OAAI
Anti-CD20 B cell depletion is associated with elevated mucosal-originating circulating regulatory IgA B cells in multiple sclerosis

抗CD20 B细胞耗竭与多发性硬化中黏膜来源的循环调节性IgA B细胞升高相关

2026-07-220
PRE
Resolution of PML after Treatment with Virus-Specific T Cells and HCT

病毒特异性T细胞和HCT治疗后PML的缓解

2026-05-280
PRE
Rethinking prognosis in multiple sclerosis: a multiaxial perspective

重新思考多发性硬化的预后:一种多轴视角

2026-05-190
PRE
Emerging CSF and Serum Biomarkers in Multiple Sclerosis

多发性硬化中新兴的脑脊液和血清生物标志物

2026-05-010
PRE
Serum metabolic profile at clinical onset as predictor of multiple sclerosis activity and progression after 5 years

临床发病时血清代谢组学特征作为预测多发性硬化活动度和5年后进展的指标

2026-04-260
PRE
Neurofilament as a biomarker of neurodegeneration in childhood Langerhans cell histiocytosis: A feasibility study on 273 patients

神经丝作为儿童朗格汉斯细胞组织细胞增生症神经退行性变的生物标志物:一项对273例患者的可行性研究

2026-04-050
PRE
Twelve-week intermittent hypoxia intervention in multiple sclerosis – a safety and feasibility trial

多发性硬化患者12周间歇性低氧干预——一项安全性与可行性试验

2026-04-020
OAAI
Serum GFAP and NfL augment a metabolomics-driven strategy for long-term prediction of multiple sclerosis progression

血清GFAP和NfL增强了代谢组学驱动的长期预测多发性硬化进展的策略

2026-02-250
OAAI
Cross-site quantitative MRI harmonization: The impact on age modeling in health and disease

多中心定量MRI数据标准化:对健康与疾病中年龄建模的影响

2026-02-241
OA